Tillar-Wenstrup Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-15,621
Closed -$2.16M 53
2018
Q3
$2.16M Sell
15,621
-664
-4% -$88.2K 1.17% 33
2018
Q2
$1.98M Buy
+16,285
New +$2.03M 1.1% 37
2017
Q4
Sell
-16,912
Closed -$2.2M 44
2017
Q3
$2.2M Sell
16,912
-708
-4% -$93.9K 1.67% 32
2017
Q2
$2.33M Sell
17,620
-216
-1% -$27.6K 1.81% 25
2017
Q1
$2.22M Buy
17,836
+16
+0.1% +$1.91K 1.7% 25
2016
Q4
$2.05M Sell
17,820
-436
-2% -$50.4K 1.73% 26
2016
Q3
$2.16M Sell
18,256
-308
-2% -$37.4K 1.97% 18
2016
Q2
$2.25M Buy
18,564
+327
+2% +$37.2K 2.23% 9
2016
Q1
$1.99M Sell
18,237
-12,175
-40% -$1.26M 2.28% 16
2015
Q4
$3.12M Sell
30,412
-71
-0.2% -$7.14K 3.09% 6
2015
Q3
$2.85M Buy
30,483
+7,656
+34% +$741K 2.86% 7
2015
Q2
$2.23M Sell
22,827
-300
-1% -$30K 2.01% 24
2015
Q1
$2.33M Buy
23,127
+10,564
+84% +$1.07M 2.27% 23
2014
Q4
$1.31M Buy
12,563
+269
+2% +$28.3K 1.27% 33
2014
Q3
$1.31M Buy
12,294
+145
+1% +$15K 1.21% 38
2014
Q2
$1.27M Buy
12,149
+177
+1% +$17.9K 1.02% 41
2014
Q1
$1.18M Buy
+11,972
New +$1.11M 1.07% 35

Other funds holding JNJ

Tillar-Wenstrup Advisors's JNJ Position: Q4 2018 in Review

Tillar-Wenstrup Advisors sold out of Johnson & Johnson (JNJ) in Q4 2018, closing a stake of 15,621 shares — an estimated $2.16M sold.

Tillar-Wenstrup Advisors first reported a position in JNJ in Q1 2014 and held it in 17 quarters. The position peaked at $3.12M in Q4 2015. 2,764 funds tracked by Wall St. Rank hold JNJ as of Q4 2018.

  • Tillar-Wenstrup Advisors reported no remaining Johnson & Johnson position as of Q4 2018 after selling out during the quarter.
  • Tillar-Wenstrup Advisors sold 15,621 Johnson & Johnson shares in Q4 2018, an estimated $2.16M.
  • Tillar-Wenstrup Advisors first reported a position in Johnson & Johnson in Q1 2014 and held it in 17 quarters.
  • Tillar-Wenstrup Advisors's Johnson & Johnson position peaked at $3.12M in Q4 2015.
  • 2,764 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2018.

Based on Tillar-Wenstrup Advisors's 13F filing for Q4 2018, filed 29 Jan 2019.